Non-GAAP gross margin is estimated to be approximately 51% for the full year and the third quarter. Adjusted EBITDA margin is estimated to be breakeven as a percent of sales for the full year and the third quarter.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- TNDM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Stifel sees Tandem underperformance as ‘overreaction’ after Mobi survey
- Tandem, DexCom announce t:slim X2 insulin pump authorized by Health Canada
- Citi opens ‘positive catalyst watch’ on Tandem Diabetes into earnings
- Tandem Diabetes Care Welcomes New EVP and COO